Associate Professor Ramazan Gozukucuk is a highly credentialed specialist in infectious diseases and clinical microbiology at Hisar Hospital Intercontinental.
Dr. Nurettin Demirkol is an internal medicine specialist at Hisar Hospital Intercontinental in Istanbul. He focus on the management of hypertension, diabetes, and thyroid diseases. Dr. Demirkol holds a master’s degree in Health Management from Okan University. He has attended over 20 national medical congresses to date.
Dr Suveyda Gozukucuk is a specialist in infectious diseases at Hisar Hospital Intercontinental with a focused interest in viral hepatitis management and infection control.
Hepatitis C treatment in Turkey reports success rates between 95% and 99%. Direct-acting antiviral drugs achieve these results within 8 to 12 weeks. Specialised centres at JCI-accredited hospitals such as Memorial Şişli Hospital treat most genotypes. Even complex cases involving cirrhosis show high cure rates.
Bookimed Expert Insight: Turkey serves over 55,000 international patients annually. This makes it the top global destination for medical requests. High-volume centres like Medipol Mega University Hospital handle up to 1,000,000 patients every year. These specialists manage complex viral loads and co-infections more frequently than doctors elsewhere.
Patient Consensus: Patients in Turkey highlight the clean facilities and well-organised diagnostic systems. They emphasise that following the antiviral regimen is vital for a successful cure.
Turkish clinics perform blood panels, liver function tests, and viral load studies before starting viral hepatitis treatment. Specialists at JCI-accredited centres like Hisar Hospital Intercontinental use these to guide therapy. Non-invasive elastography often replaces biopsy to assess liver stiffness without surgery.
Bookimed Expert Insight: Patient volume serves as a strong quality signal in Turkey. Medipol Mega University Hospital treats over 1,000,000 patients annually. High-volume specialists like Assoc. Prof. Dr. Ramazan Gozukucuk at Hisar Hospital manage complex viral hepatitis cases daily. This depth of experience often leads to more precise diagnostic interpretations for rare viral strains.
Patient Consensus: Patients in Turkey find the diagnostic process very well organised with clear explanations about treatment methods. They note that appointments run on time and doctors provide professional consultations.
Chronic Hepatitis B cannot be completely cured in Turkey or elsewhere. However, Turkish specialists use high-potency antivirals for a functional cure. This suppresses the virus to undetectable levels and prevents liver damage using JCI-accredited protocols. Clinics use specialised diagnostics to monitor patient health.
Bookimed Expert Insight: Turkish university hospitals like Medipol Mega serve nearly 1,000,000 patients annually. This massive volume allows hepatologists to manage rare drug-resistant strains. While A$100 consultations provide initial clarity, the true value lies in PET-CT access. This sensitivity is 4x higher than standard scans for spotting early liver changes.
Patient Consensus: Patients in Turkey find the diagnostics efficient. They emphasise that while standard treatments manage the virus, there is no complete cure. Sentiments suggest that doctors are professionals who provide very clear explanations about management methods.
Infectious disease specialists and gastroenterologists primarily oversee viral hepatitis treatment in Turkey. These experts manage antiviral protocols and liver monitoring at JCI-accredited facilities in Istanbul and Antalya. Many hold international fellowships and certifications from the Turkish Ministry of Health.
Bookimed Expert Insight: Turkish specialists often hold dual competencies in infectious diseases and clinical microbiology. For instance, doctors at Hisar Hospital Intercontinental maintain specific certificates in both fields. This allows them to interpret molecular viral results and tailor antiviral treatments. This integration speeds up treatment starts compared to systems with separate pathology and clinical care.
Patient Consensus: Patients in Turkey find diagnostics very fast. They also appreciate the clear explanations provided during specialist consultations. It is common to consult a gastroenterologist first for a baseline assessment of liver health.
Hepatitis C treatment in Turkey typically lasts 8 to 12 weeks using oral Direct-Acting Antiviral medications. Most patients achieve a cure within 12 weeks. Specialists may extend treatment to 24 weeks for complex cases involving liver cirrhosis or previous treatment failure.
Bookimed Expert Insight: Turkey's massive patient volume ensures doctors manage Hepatitis C cases efficiently. Medipol Mega serves 1,000,000 patients annually. JCI-accredited centres often bundle specialist consultations and viral load tests into one visit. This helps Australian patients save time before starting their 8 to 12-week medication course.
Patient Consensus: Patients in Turkey find the diagnostics well-organised. They note that doctors provide very clear explanations about the disease and specific treatment methods.
Australian citizens generally need a medical visa for hepatitis treatment in Turkey if the stay exceeds 90 days. It is also required if the primary purpose is clinical care. Tourists often enter via the e-visa portal. However, medical travellers should get a formal invitation letter and apply through the HealthTurkiye portal.
Bookimed Expert Insight: Turkish hospitals like Anadolu Medical Center or Medipol Mega serve over 65,000 to 1,000,000 patients annually. These centres handle massive international volumes. They have dedicated departments to issue the specific invitation letters required for medical visa approvals. Choosing a hospital with JCI accreditation often streamlines the paperwork for Australian patients.
Patient Consensus: Patients in Turkey report that clinics are professional and clean. However, documentation must be organised early. They suggest confirming that your visa covers the full treatment schedule. Always request clear treatment plans before flying.
Turkish hospitals provide specialised care for international hepatitis patients. JCI-accredited facilities such as Memorial Şişli Hospital and Hisar Hospital Intercontinental employ infectious disease specialists and hepatologists. These centres manage chronic conditions like Hepatitis B and C using modern antiviral therapies and diagnostic imaging.
Bookimed Expert Insight: Turkey's massive patient volume provides a unique advantage for hepatitis care. Medipol Mega University Hospital alone serves 1,000,000 patients annually. This high turnover means infectious disease departments handle diverse viral strains daily. They also manage complex liver complications. Australian patients benefit from doctors who see numerous hepatitis cases each month.
Patient Consensus: Patients find Turkish clinics clean and staff helpful. Many praise the fast diagnostics and clear explanations regarding disease management. Consultations feel efficient and professional. However, patients note it is important to pre-book appointments. They also suggest confirming all service fees upfront.